Literature DB >> 9161401

Complete regression of primary cutaneous malignant melanoma.

S W Menzies1, W H McCarthy.   

Abstract

While partial spontaneous histopathological regression is a common finding in invasive primary melanoma, proven complete regression is rare, with only 33 cases having been documented. None of the patients in these reported cases had a biopsy specimen taken from the original lesion, which would unequivocally prove the diagnosis of complete regressing melanoma. Over 4 years, we saw a 62-year-old white man who refused treatment of a biopsy specimen-proved superficial spreading melanoma (Breslow thickness, 0.7 mm) that eventually regressed completely. A biopsy specimen confirmed complete histopathological regression. There was no clinical evidence of regional or distant metastases throughout the 4 years. To our knowledge, this is the first documented case of a biopsy specimen-proved primary melanoma completely regressing. We present sequential photographic documentation and review the literature about this phenomenon. While the prevalence of such an event is unknown, evidence is presented that it may be more common than previously thought.

Entities:  

Mesh:

Year:  1997        PMID: 9161401     DOI: 10.1001/archsurg.1997.01430290099020

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  14 in total

Review 1.  Melanoma-associated leukoderma - immunology in black and white?

Authors:  Hadas Prag Naveh; Uma N M Rao; Lisa H Butterfield
Journal:  Pigment Cell Melanoma Res       Date:  2013-10-09       Impact factor: 4.693

2.  A new animal model for the imaging of melanoma: correlation of FDG PET with clinical outcome, macroscopic aspect and histological classification in Melanoblastoma-bearing Libechov Minipigs.

Authors:  Raphaël Boisgard; Silvia Vincent-Naulleau; Jean-Jacques Leplat; Stephan Bouet; Catherine Le Chalony; Yves Tricaud; Vratislav Horak; Claudine Geffrotin; Gérard Frelat; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-08       Impact factor: 9.236

3.  Management decisions for nodal metastasis from an unknown primary melanoma.

Authors:  Chris C Lee; Mark B Faries; Donald L Morton
Journal:  Am J Hematol Oncol       Date:  2008-07-01

Review 4.  Melanoma in immunosuppressed patients.

Authors:  Agnieszka W Kubica; Jerry D Brewer
Journal:  Mayo Clin Proc       Date:  2012-10       Impact factor: 7.616

5.  [Regression in malignant melanoma. Definition, etiopathogenesis, morphology and differential diagnosis].

Authors:  B E Paredes
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

6.  Fully Regressive Melanoma: A Case Without Metastasis.

Authors:  Eric Ehrsam; Joseph R Kallini; Damien Lebas; Amor Khachemoune; Philippe Modiano; Hervé Cotten
Journal:  J Clin Aesthet Dermatol       Date:  2016-08-01

Review 7.  [Primary malignant melanoma of the parotid gland: a case report and review of the literature].

Authors:  H Maier; G Mühlmeier; K Kraft; N M Blumstein; M Tisch
Journal:  HNO       Date:  2008-06       Impact factor: 1.284

Review 8.  Melanocytic nevi simulant of melanoma with medicolegal relevance.

Authors:  Guido Massi
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

Review 9.  Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients.

Authors:  Aljosja Rogiers; Joost J van den Oord; Marjan Garmyn; Marguerite Stas; Cindy Kenis; Hans Wildiers; Jean-Christophe Marine; Pascal Wolter
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

10.  Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour.

Authors:  Benjamin Weide; Christine Faller; Margrit Elsässer; Petra Büttner; Annette Pflugfelder; Ulrike Leiter; Thomas Kurt Eigentler; Jürgen Bauer; Friedegund Meier; Claus Garbe
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.